FollowMyHealth Patient Portal

Faculty Physicians

Ken Yamaguchi, MD

Professor, Orthopedic Surgery
Sam and Marilyn Fox Distinguished Professor of Orthopaedic Surgery
Vice Chair, Quality and Research - Orthopaedic Surgery

Specialty Areas

Orthopedic Surgery
Shoulder and Elbow Surgery

Board Certifications

Orthopedic Surgery

Areas of Clinical Interest

Orthopedics, degenerative, traumatic, and orthopedic sports disorders of the shoulder and elbow, arthroscopic surgery, minimally invasive surgery, rotator cuff disorders, degenerative arthritis of the shoulder, rheumatic arthritis of the shoulder and elbow, instability, frozen shoulder, fracture treatment, repetitive motion disorders

  • Maps & Directions
  • Education
  • Publication & Research
  • Financial Disclosures

Maps & Directions

Maps & Directions

Washington University and Barnes-Jewish Orthopedic Center

14532 S. Outer 40 Drive
Chesterfield, MO 63017

Office Phone: 314-514-3500

Center for Advanced Medicine
Neurosurgical Cervical Spine Institute and Spine Center

4921 Parkview Place
St. Louis, MO 63110

Suite: A
Floor: 12
Office Phone: 314-514-3500
Fax: 314-747-2266

Education

Education

Fellowship: Shoulder and Elbow, Columbia Presbyterian Medical Center, New York, New York 1995
Residency: Orthopedic Surgery, George Washington University, Washington D.C. 1994
Medical School: George Washington University, Washington, DC 1989

Publication & Research

Publication & Research

Serial imaging changes during treatment of immunoglobulin G4-related disease with multiple pseudotumors.
Kusunose K, Hotchi J, Takagawa Y, Nishio S, Ise T, Tobiume T, Yamaguchi K, Yagi S, Iwase T, Yamada H, Soeki T, Wakatsuki T, Sata M
Circulation. 2015 May 26; 131(21)1882-3. doi: 10.1161/CIRCULATIONAHA.115.015638.

PMID:
    26015466
    [PubMed - indexed for MEDLINE]
Related citations


Randomized trial of TAS-102 for refractory metastatic colorectal cancer.
Mayer RJ, Van Cutsem E, Falcone A, Yoshino T, Garcia-Carbonero R, Mizunuma N, Yamazaki K, Shimada Y, Tabernero J, Komatsu Y, Sobrero A, Boucher E, Peeters M, Tran B, Lenz HJ, Zaniboni A, Hochster H, Cleary JM, Prenen H, Benedetti F, Mizuguchi H, Makris L, Ito M, Ohtsu A, RECOURSE Study Group
N Engl J Med. 2015 May 14; 372(20)1909-19. doi: 10.1056/NEJMoa1414325.

PMID:
    25970050
    [PubMed - indexed for MEDLINE]
Related citations


Additional Surgery After Non-curative Resection of ESD for Early Gastric Cancer.
Katsube T, Murayama M, Yamaguchi K, Usuda A, Shimazaki A, Asaka S, Konnno S, Miyaki A, Usui T, Yokomizo H, Shiozawa S, Yoshimatsu K, Shimakawa T, Naritaka Y
Anticancer Res. 2015 May; 35(5)2969-74.

PMID:
    25964583
    [PubMed - indexed for MEDLINE]
Related citations


[A questionnaire survey on QOL and toxicity in colorectal cancer survivors who received adjuvant chemotherapy].
Taniguchi H, Narita Y, Komori K, Kimura K, Kinoshita T, Komori A, Uegaki S, Nomura M, Nitta S, Yamaguchi K, Kadowaki S, Takahari D, Ura T, Andoh M, Muro K
Gan To Kagaku Ryoho. 2015 Apr; 42(4)457-61.

PMID:
    25963692
    [PubMed - indexed for MEDLINE]
Related citations


Elevated Concentration of Interferon-Inducible Protein of 10 kD (IP-10) Is Associated With Coronary Atherosclerosis.
Niki T, Soeki T, Yamaguchi K, Taketani Y, Yagi S, Iwase T, Yamada H, Wakatsuki T, Shimabukuro M, Sata M
Int Heart J. 2015 May 13; 56(3)269-72. doi: 10.1536/ihj.14-300.

PMID:
    25902883
    [PubMed - indexed for MEDLINE]
Related citations


Randomised phase II trial of S-1 plus oxaliplatin vs S-1 in patients with gemcitabine-refractory pancreatic cancer.
Ohkawa S, Okusaka T, Isayama H, Fukutomi A, Yamaguchi K, Ikeda M, Funakoshi A, Nagase M, Hamamoto Y, Nakamori S, Tsuchiya Y, Baba H, Ishii H, Omuro Y, Sho M, Matsumoto S, Yamada N, Yanagimoto H, Unno M, Ichikawa Y, Takahashi S, Watanabe G, Wakabayashi G, Egawa N, Tsuda M, Hosotani R, Hamada C, Hyodo I
Br J Cancer. 2015 Apr 28; 112(9)1428-34. doi: 10.1038/bjc.2015.103.

PMID:
    25880004
    [PubMed - indexed for MEDLINE]
Related citations


Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study.
Tabernero J, Yoshino T, Cohn AL, Obermannova R, Bodoky G, Garcia-Carbonero R, Ciuleanu TE, Portnoy DC, Van Cutsem E, Grothey A, Prausová J, Garcia-Alfonso P, Yamazaki K, Clingan PR, Lonardi S, Kim TW, Simms L, Chang SC, Nasroulah F, RAISE Study Investigators
Lancet Oncol. 2015 May; 16(5)499-508. doi: 10.1016/S1470-2045(15)70127-0.

PMID:
    25877855
    [PubMed - indexed for MEDLINE]
Related citations


IFN-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer.
Abiko K, Matsumura N, Hamanishi J, Horikawa N, Murakami R, Yamaguchi K, Yoshioka Y, Baba T, Konishi I, Mandai M
Br J Cancer. 2015 Apr 28; 112(9)1501-9. doi: 10.1038/bjc.2015.101.

PMID:
    25867264
    [PubMed - indexed for MEDLINE]
Related citations


[Clinical guidelines of pancreatic cancer 2013: a synopsis].
Yamaguchi K
Nihon Rinsho. 2015 Mar; 73 Suppl 3393-9.

PMID:
    25857055
    [PubMed - indexed for MEDLINE]
Related citations


[Pancreatic ductal carcinoma derived from IPMN and concomitant with IPMN].
Yamaguchi K
Nihon Rinsho. 2015 Mar; 73 Suppl 3234-9.

PMID:
    25857022
    [PubMed - indexed for MEDLINE]
Related citations


[Algorithm for treatment of pancreatic cancer].
Yamaguchi K
Nihon Rinsho. 2015 Mar; 73 Suppl 3125-8.

PMID:
    25856999
    [PubMed - indexed for MEDLINE]
Related citations


Integration of published information into a resistance-associated mutation database for Mycobacterium tuberculosis.
Salamon H, Yamaguchi KD, Cirillo DM, Miotto P, Schito M, Posey J, Starks AM, Niemann S, Alland D, Hanna D, Aviles E, Perkins MD, Dolinger DL
J Infect Dis. 2015 Apr 1; 211 Suppl 2S50-7. doi: 10.1093/infdis/jiu816.

PMID:
    25765106
    [PubMed - indexed for MEDLINE]
Related citations


Novel biological activity of ameloblastin in enamel matrix derivative.
Kuramitsu-Fujimoto S, Ariyoshi W, Saito N, Okinaga T, Kamo M, Ishisaki A, Takata T, Yamaguchi K, Nishihara T
J Appl Oral Sci. 2015 Jan-Feb; 23(1)49-55. doi: 10.1590/1678-775720140291.

PMID:
    25760267
    [PubMed - indexed for MEDLINE]
Related citations


[Stevens-Johnson syndrome induced by regorafenib in a patient with progressive recurrent rectal carcinoma].
Mihara Y, Yamaguchi K, Nakama T, Nakayama G, Kamei H, Ishibashi N, Uchida S, Akagi Y, Ogata Y
Gan To Kagaku Ryoho. 2015 Feb; 42(2)233-6.

PMID:
    25743146
    [PubMed - indexed for MEDLINE]
Related citations


Impact of supervised cardiac rehabilitation on urinary albumin excretion in patients with cardiovascular disease.
Kimura S, Ueda Y, Ise T, Yagi S, Iwase T, Nishikawa K, Yamaguchi K, Yamada H, Soeki T, Wakatsuki T, Katoh S, Akaike M, Yasui N, Sata M
Int Heart J. 2015; 56(1)105-9. doi: 10.1536/ihj.14-161.

PMID:
    25742947
    [PubMed - indexed for MEDLINE]
Related citations


[Experiences of laparoscopic repeat hepatectomy for recurrent hepatic cancer after open hepatectomy].
Matsukawa H, Shiozaki S, Satoh D, Yoshida K, Miyoshi H, Araki H, Idani H, Ojima Y, Harano M, Kanazawa T, Tokumoto N, Choda Y, Miyake S, Kato T, Mimura N, Takahashi K, Yamaguchi K, Okajima M, Ninomiya M
Gan To Kagaku Ryoho. 2014 Nov; 41(12)2098-100.

PMID:
    25731435
    [PubMed - indexed for MEDLINE]
Related citations


[A case of intrahepatic cholangiocarcinoma with peritoneal dissemination treated successfully with surgical resection and adjuvant chemotherapy].
Shiozaki S, Satoh D, Matsukawa H, Yamaguchi K, Takahashi K, Mimura N, Taguchi K, Araki H, Toshima T, Kato T, Miyake S, Miyoshi H, Yoshida K, Choda Y, Tokumoto N, Kanazawa T, Harano M, Ojima Y, Idani H, Okajima M, Ninomiya M
Gan To Kagaku Ryoho. 2014 Nov; 41(12)2089-91.

PMID:
    25731432
    [PubMed - indexed for MEDLINE]
Related citations


[Successful resection of recurrent lesions in a patient with ovarian torsion diagnosed with rectal cancer].
Shimojima Y, Yoshimatsu K, Yokomizo H, Yano Y, Nakayama M, Okayama S, Satake M, Matsumoto A, Fujimoto T, Usui T, Yamaguchi K, Shiozawa S, Shimakawa T, Katsube T, Naritaka Y
Gan To Kagaku Ryoho. 2014 Nov; 41(12)1808-10.

PMID:
    25731337
    [PubMed - indexed for MEDLINE]
Related citations


[The case of a patient who experienced perforation related to sigmoid colon cancer, was bearing a hepatic metastasis, and who underwent radical resection for advanced colon cancer after a salvage operation for pan-peritonitis and chemotherapy].
Murayama M, Nakashima O, Yamazaki K, Koizumi K, Miyauchi T, Miyaki A, Usuda A, Yamaguchi K, Yokomizo H, Shiozawa S, Yoshimatsu K, Shimakawa T, Katsube T, Naritaka Y
Gan To Kagaku Ryoho. 2014 Nov; 41(12)1782-4.

PMID:
    25731328
    [PubMed - indexed for MEDLINE]
Related citations


[Effect of chemotherapy on the inoperable or recurrent colorectal cancers in patients with lynch syndrome].
Suzuki O, Kumamoto K, Chika N, Fukuchi M, Kumagai Y, Ishibashi K, Mochiki E, Akagi K, Yamaguchi K, Ishida H
Gan To Kagaku Ryoho. 2014 Nov; 41(12)1770-2.

PMID:
    25731324
    [PubMed - indexed for MEDLINE]
Related citations

Financial Disclosures

Financial Disclosures

Disclosure of Financial Interests with Industry

Washington University and its physicians are committed to ensuring integrity and objectivity in medical decision-making. Some of our physicians work collaboratively with pharmaceutical or medical device companies to develop innovative ideas and products that can improve health care delivery and clinical outcomes for patients. In some instances, our faculty physicians are paid by these commercial companies to provide advice on product design or to speak about the use of medications, devices, equipment or procedures. These payments may include: a) compensation for consulting and speaking engagements, b) equity, and/or c) royalties for products invented by our faculty. Any payments to Washington University physicians must be based on tangible services and may not exceed fair market value for their work. In addition to disclosure on this web site, physicians earning more than $10,000 per year must disclose their corporate financial relationship in writing to patients when prescribing or using that company's products.

This physician reported the following earned financial interests during calendar year 2014.

Company Name: Tornier

Royalties: $50,001 - $100,000

Equity: No

Consulting/Advisory Board:

Speaker Fees:

Reporting Date: May 01, 2015


Company Name: Zimmer

Royalties: $50,001 - $100,000

Equity: No

Consulting/Advisory Board:

Speaker Fees:

Reporting Date: May 01, 2015